Medtronic

By Dave Muoio January 3, 2019
Sugar.IQ — the digital diabetes assistant for Guardian Connect system users that is jointly supported by Medtronic and IBM Watson — has a new feature that uses artificial intelligence to predict future low glucose events. Called IQcast, the feature tells users whether they have a low, medium or high chance of dropping below the target blood glucose range within the next one to four hours. These...
By Dave Muoio December 18, 2018
The FDA has approved an app-based smart programming device used to discreetly and easily control implants treating for overactive bladder (OAB), chronic fecal incontinence (FI) and non-obstructive urinary retention, medical device maker Medtronic announced yesterday. Called the InterStim smart programmer and designed for use with Medtronic’s InterStim system, the product consists of a Samsung...
By Laura Lovett November 21, 2018
Medtronic has announced that it will acquire long-time partner Nutrino, an AI powered personalized nutrition platform for an undisclosed sum. As part of the deal Medtronic will be integrating Nutrino’s AI-driven personalized insights and food database. The acquisition is set to specifically boost Medtronic’s offerings for people living with diabetes and offer the company’s predictive glycemic...
By Laura Lovett August 16, 2018
A recent study published in JAMA Surgery found that when it comes to reporting conflicts of interest in regards to compensation from medical device companies, doctors aren’t always completely forthcoming.  Researchers discovered that only 37.3 percent of publications written by a sample of doctors receiving the greatest compensation from device companies declared all relevant conflicts of...
By Laura Lovett July 18, 2018
Israel is continuing to carve out its space as a digital health hub in the Middle East. Today the Israeli government announced a $33 million grant aimed at furthering the country's foothold in digital health, specifically in biotech and medicine, according to Reuters. Medtronic, GE Healthcare, and Change Healthcare were named the three recipients of the funding; each company will get a different...
By Dave Muoio July 11, 2018
In 2016, UnitedHealthcare and Medtronic cut a deal that established the latter’s devices as the preferred insulin pumps for United members with diabetes. Now, the companies have announced year one data suggesting that members who took advantage of the companies’ arrangement experienced fewer preventable hospital admissions when compared to members relying on multiple daily injections of insulin...
By MobiHealthNews July 5, 2018
Interest in digital health is now sprouting up all over DC, from the president’s announcement of a new AI task force to FDA Commissioner’s shout out to digital health in his budget request.   In fact, the FDA is turning to developers in the digital health space to help solve some of the country’s most difficult problems. In May, the agency announced an innovation challenge aimed at tackling the...
By Laura Lovett June 25, 2018
Two years after originally announcing it, Medtronic and IBM Watson have launched their joint platform the Sugar.IQ, a digital diabetes assistant.  “It is designed for people who are currently using Guardian Connect; so made for people on multiple daily injections. It is a personal assistant a little bit like Alexa or Siri,” Huzefa Neemuchwala, global head of digital health solutions and AI at...
By Dave Muoio June 25, 2018
This weekend saw the kickoff of the American Diabetes Association’s 78th annual conference, and with it a slew of new data from diabetes management players. The meeting included presentation on studies covering a range of technologies, such as continuous glucose monitors, insulin pumps, apps, and other digital-backed management strategies. Among the studies highlighted by the association was an...
By Laura Lovett June 22, 2018
Children with Type 1 diabetes will now have access to the Medtronic MiniMed 670G, a hybrid closed-loop system insulin delivery system, following the FDA’s decision to expand the product approval for a younger demographic.  In 2016 the device became the first FDA-approved continuous glucose monitoring system that controls automated insulin delivery via a hybrid closed loop system. But at that time...

Editor's Pick